Major Molecular Response in CML Patients Treated with Tyrosine Kinase Inhibitors: The Paradigm for Monitoring Targeted Cancer Therapy
Year: 2010
Type: article
Abstract: This article examines the role of real-time quantitative polymerase chain reaction testing of BCR-ABL transcript levels to assess minimal residual disease and outcomes in patients with chronic myeloid leukemia.
Source: The Oncologist
Author: Richard D. Press
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2764683163